People who have struggled to maintain weight loss through lifestyle changes alone are often the population where tirzepatide may be appropriate after a licensed-provider evaluation
Molecule and mechanism matter
"What began as a diabetes therapy has become a cultural phenomenon a magic shot changing bodies, markets, and mindsets worldwide." excerpt from the article Semaglutide, Tirzepatide, GLP-1 and GIP: What Are They and Why Have They Caused Such a Stir? First of all, these drugs have proven to be very effective in treating type 2 diabetes and have demonstrated previously unattainable effectiveness in the medical treatment of obesity, allowing patients who receive them to lose up to 20-25% of their initial body weight
So, peripherally dosed long-acting GLP-1RAs have the ability to access neurons in both the CVOs and in a few select sites in the hypothalamus, but do not broadly cross the blood brainbarrier
When decreasing, drop back to the last dose that you tolerated well and stay there for at least four weeks before attempting to increase again